Stage I Bladder Cancer AJCC v8 Clinical Trials

12 clinical trials for Stage I Bladder Cancer AJCC v8 across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial — RECRUITING · PHASE2
• Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy — RECRUITING · PHASE3
• Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial — RECRUITING · NA
• In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial — RECRUITING · PHASE1
• PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer — RECRUITING · PHASE1
• Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study — ACTIVE_NOT_RECRUITING
• Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes — COMPLETED
• Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship — COMPLETED · PHASE1
• Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy — COMPLETED · PHASE2
• Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer — COMPLETED · PHASE2

Refine this search